Adult Acinetobacter meningitis and its comparison with non-Acinetobacter gram-negative bacterial meningitis
Shu-Fang Chen1, Wen-Neng Chang, Cheng-Hsien Lu
1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung, Kaohsiung, Taiwan.
Abstract:
Between January 1999 and December 2003, 81 cases of single pathogen-related culture-proven Gram-negative adult bacterial meningitis were identified at Chang Gung Memorial Hospital-Kaohsiung. Of these 81 cases, Acinetobacter infection was found in 13 cases. Clinical and laboratory data of these Acinetobacter meningitis patients were studied and were compared with those of other 68 non-Acinetobacter Gram-negative bacterial meningitis (GNBM) patients. Of the 13 implicated Acinetobacter strains, A. baumannii was the most common (12), and the other was A. lwoffii (1). Eleven of these 13 cases were due to a post-neurosurgical infection. The results of the antibiotic susceptibility test of the 13 Acinetobacter strains from cerebrospinal fluid included ceftriaxone, (1/13, 8%), ciprofloaxin (6/13, 46%), ceftazidime (6/13, 46%), cefepime (7/13, 54%), ampicillin-subtactam (7/13, 54%), imipenem (12/13, 92%) and meropenem (12/13, 92%). One strain with pan-drug resistant A. baumannii (PDRAB) emerged in 2003. A statistically significant difference between Acinetobacter meningitis and non-Acinetobacter GNBM included hydrocephalus and ceftazidime-resistance. A mortality rate was 30% (4/13), and 7 of the other 9 survivals had severe neurologic deficits. The emergence of Acinetobacter infections in adult post-neurosurgical infections, multiple antibiotic resistant characteristics, and the emergence of PDRAB strain remained a challenge of the initial management of this specific meningitis. Use of carbapenem, especially meropenem, could be considered as one of the initial empiric antibiotics chosen for the management of adult post-neurosurgical meningitis.
Insights
Acinetobacter meningitis, particularly post-neurosurgical cases, shows high antibiotic resistance. Meropenem is a potential initial treatment for this challenging Gram-negative bacterial meningitis.
Area of Science:
- Infectious Diseases
- Neuroscience
- Microbiology
Background:
- Gram-negative bacterial meningitis (GNBM) is a serious infection.
- Acinetobacter species are increasingly recognized pathogens, especially in hospital-acquired infections.
- Post-neurosurgical meningitis presents unique management challenges due to potential resistance patterns.
Purpose of the Study:
- To investigate the clinical features and antibiotic susceptibility of Acinetobacter meningitis in adult patients.
- To compare Acinetobacter meningitis with other Gram-negative bacterial meningitis (GNBM) cases.
- To identify challenges and guide initial management strategies for Acinetobacter meningitis.
Main Methods:
- Retrospective analysis of 81 adult bacterial meningitis cases from 1999-2003.
- Comparison of 13 Acinetobacter meningitis cases with 68 non-Acinetobacter GNBM cases.
- Analysis of antibiotic susceptibility testing for Acinetobacter strains from cerebrospinal fluid.
Main Results:
- Acinetobacter meningitis occurred in 13 cases, predominantly A. baumannii (12/13), with 11 post-neurosurgical infections.
- High resistance rates were observed for ceftriaxone (8%), ciprofloxacin (46%), ceftazidime (46%), cefepime (54%), ampicillin-sulbactam (54%), with high susceptibility to imipenem (92%) and meropenem (92%).
- A pan-drug resistant A. baumannii strain emerged in 2003. Acinetobacter meningitis was associated with hydrocephalus and ceftazidime resistance. Mortality was 30%, with significant neurological deficits in survivors.
Conclusions:
- Acinetobacter meningitis, especially in post-neurosurgical settings, is challenging due to multidrug resistance and the emergence of pan-drug resistant strains.
- Carbapenems, particularly meropenem, should be considered for initial empiric antibiotic therapy in adult post-neurosurgical meningitis.
- Early recognition and appropriate antibiotic selection are crucial for improving outcomes in Acinetobacter meningitis.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Viral Meningitis
Brain Abscess l: Introduction
Atypical Pneumonia
